Kraig Biocraft Laboratories Confirms Reports in Vietnamese Media That the Company's CEO is Meeting With High Ranking Governme...
January 09 2014 - 6:05AM
Kraig Biocraft Laboratories, Inc. (OTCQB:KBLB) ("Company"), the
leading developer of advanced spider silk based fibers, announced
today that the Company has been meeting with high level Vietnamese
government officials, regarding the establishment of advanced fiber
production in Vietnam. Reports of these meetings have been
receiving wide coverage in Vietnamese press and television.
An example of the Vietnamese coverage can be found at the
following link:
http://vovworld.vn/en-US/News/Kraig-Biocraft-Laboratories-CEO-welcomed-in-Hanoi/207937.vov
"Vietnam is a nation with a wealth of infrastructure and
experience in raw silk fiber production," said Company CEO and
Founder, Kim K. Thompson. "We believe there is a natural fit
between our desire to achieve large scale commercial production and
Vietnam's desire to modernize its industry and increase
productivity," continued Thompson.
"We are very excited about the possibility of working with
Vietnam. Our discussions regarding commercial production have
been very productive. We have been very well received and our
hosts have been very gracious. I would like to thank the
parties who have taken the time to help make this trip as fruitful
as possible. I am very impressed with what I've seen in
Vietnam, including their passion for sericulture," Thompson
concluded.
The Company's CEO will continue a thorough evaluation and
assessment process in Vietnam, before returning to the United
States.
About Kraig Biocraft Laboratories, Inc.
Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a fully
reporting biotechnology company is the leading developer of
genetically engineered spider silk based fiber technologies. The
Company has achieved a series of scientific breakthroughs in the
area of spider silk technology with implications for the global
textile industry.
Cautionary Statement Regarding Forward Looking Information
Statements in this press release about the Company's future and
expectations other than historical facts are "forward-looking
statements." These statements are made on the basis of management's
current views and assumptions. As a result, there can be no
assurance that management's expectations will necessarily come to
pass. These forward-looking statements generally can be identified
by phrases such as "believes," "plans," "expects," "anticipates,"
"foresees," "estimated," "hopes," "if," "develops," "researching,"
"research," "pilot," "potential," "could" or other words or phrases
of similar import. Forward looking statements include descriptions
of the Company's business strategy, outlook, objectives, plans,
intentions and goals. All such forward-looking statements are
subject to certain risks and uncertainties that could cause actual
results to differ materially from those in forward-looking
statements.
This press release does not constitute an offer to sell or the
solicitation of an offer to buy any security.
CONTACT: Ben Hansel, Hansel Capital, LLC.
(720) 288-8495
ir@KraigLabs.com
Kraig Biocraft Laborator... (QB) (USOTC:KBLB)
Historical Stock Chart
From Mar 2024 to Apr 2024
Kraig Biocraft Laborator... (QB) (USOTC:KBLB)
Historical Stock Chart
From Apr 2023 to Apr 2024